Our Press Releases | Association for Accessible Medicines

AAM All Access Podcast - AAM CEO Dan Leonard convenes industry and policy experts to explore why the Inflation Reduction Act (f/k/a Build Back Better) reduces generic and biosimilar competition.

Capitol Building - Washington D.C.

Aug 7, 2022 | Allen Goldberg

AAM Statement on Senate Passage of Inflation Reduction Act

David Gaugh at GRx+Biosims (North Bethesda, Maryland)

Jul 28, 2022 | Allen Goldberg

Association for Accessible Medicines (AAM) Elevates David Gaugh to Executive Vice President for Sciences & Regulatory Affairs

Misguided Drug Pricing Reform

Jul 6, 2022 | Allen Goldberg

AAM Statement on BBB 2.0

Drug manufacture

Jun 6, 2022 | Allen Goldberg

Giuseppe Randazzo Joins AAM as Vice President, Sciences and Regulatory Affairs

Ariel with Medicines

May 23, 2022 | Allen Goldberg

AAM Statement in Response to Federal Trade Commission Request for Information on PBM Business Practices

May 16, 2022 | Allen Goldberg

Association for Accessible Medicines Names Craig Burton as Senior Vice President, Policy & Strategic Alliances, and Executive Director of the Biosimilars Council

Headquarter of the U.S. Food and Drug Administration (FDA)

May 11, 2022 | Allen Goldberg

AAM Statement on House Energy and Commerce Health Subcommittee Markup of H.R. 7667 Reauthorizing Generic Drug and Biosimilar User Fee Amendments

Apr 1, 2022 | Rachel Schwartz

HHS Finds Biosimilars Use Results in “Significant Spending Reduction” For Medicare and Its Beneficiaries

Dr. Robert Califf

Feb 15, 2022 | Rachel Schwartz

AAM Statement on the Confirmation of Robert Califf to Lead FDA

Academy of Managed Care Pharmacy (AMCP)

Feb 15, 2022 | Rachel Schwartz

Academy of Managed Care Pharmacy Named AAM’s 2022 Champion of Access

AAM board room

Feb 14, 2022 | Rachel Schwartz

Chirag Patel Named Chair of the Association for Accessible Medicines Board of Directors

AAM board room

Feb 14, 2022 | Rachel Schwartz

AAM Announces 2022 Board of Directors